Voloridge Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $165K | Sell |
|
|||||
|
2025
Q1 | $4.81M | Buy |
|
|||||
|
2024
Q4 | $1.63M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.07M | Sell |
|
|||||
|
2024
Q1 | $1.85M | Sell |
|
|||||
|
2023
Q4 | $1.9M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4.58M | Sell |
|
|||||
|
2021
Q1 | $5.63M | Buy |
|
|||||
|
2020
Q4 | $2.84M | Sell |
|
|||||
|
2020
Q3 | $3.39M | Sell |
|
|||||
|
2020
Q2 | $5.75M | Buy |
|
|||||
|
2020
Q1 | $432K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $698K | Sell |
|
|||||
|
2018
Q3 | $4.06M | Buy |
|
|||||
|
2018
Q2 | $3.29M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.26M | Buy |
|